Skip to search formSkip to main contentSkip to account menu

Bupropion

Known as: Amfebutamone, (+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone, BUP 
An aminoketone with antidepressant activity. The molecular mechanism of the antidepressant effect of bupropion is unknown. This agent does not… 
National Institutes of Health

Related topics

Related topics

39 relations
12 HR Bupropion Hydrochloride 100 MG Extended Release Oral Tablet [Wellbutrin]12 HR Bupropion Hydrochloride 150 MG Extended Release Oral Tablet24 HR Bupropion Hydrochloride 300 MG Extended Release Oral Tablet [Wellbutrin]24 HR Bupropion hydrobromide 348 MG Extended Release Oral Tablet [Aplenzin]

Broader (5)

Antidepressive AgentsAntidepressive Agents, Second-GenerationBupropion HydrochlorideCytochrome P-450 CYP2D6 Inhibitors

Narrower (9)

AplenzinBudeprionContraveQuomen

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Delayed loss of efficacy and depressogenic action of antidepressants.
2001
2001
Improved Health-Related Quality of Life and Reduced Productivity Loss After Treatment With Bupropion Sustained Release: A Study in Patients With Major Depression.
BACKGROUND: This open-label portion of a 2-phase study assessed the effects of the antidepressant bupropion sustained release (SR… 
2000
2000
[Successful treatment of depression in a Parkinson disease patient with bupropion].
A 70-year-old female patient with Parkinson's disease was admitted to hospital with a medication-resistant depression… 
2000
2000
Nicotine reduction: effectiveness of bupropion.
Hayford et al ([1999][1]) and others have found sustained-release bupropion useful as part of nicotine reduction treatment… 
1999
1999
Zyban: a new aid to smoking cessation treatment--will it work for psychiatric patients?
: 1. Psychiatric patients who smoke are more highly dependent on nicotine and are less likely to be successful at quitting. When… 
Highly Cited
1984
Highly Cited
1984
Butylphenyl dGTP: a selective and potent inhibitor of mammalian DNA polymerase alpha.
BuPdGTP , the 2'-deoxyribonucleoside 5'-triphosphate of the DNA polymerase alpha (pol alpha)-specific inhibitor, N2-(p-n… 
1983
1983
Effects of bupropion on body weight.
Patients' weights were assessed during placebo-controlled, amitriptyline-controlled, and uncontrolled bupropion trials. Low… 
1983
1983
Psychopharmacology of bupropion in normal volunteers.
In each of four studies of the human pharmacology of bupropion, 12 healthy volunteers received 6 different treatments, including… 
1983
1983
Failure of bupropion to affect prolactin or growth hormone in man.
In a double-blind crossover design, 5 male and 5 female volunteers received 5 different oral single-dose bupropion treatments (12… 
1983
1983
Long-term preventive care in depression: the use of bupropion in patients intolerant of other antidepressants.
: The safety and efficacy of bupropion in the preventive care of depression was studied in a long-term open trial. Forty patients…